Test-retest Study With [18F]PI-2620 in PSP-RS and NDC

Condition:   Progressive Supranuclear Palsy Intervention:   Drug: [18F]-PI2620 Sponsor:   Life Molecular Imaging GmbH Recruiting

Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials